{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:33:27Z","timestamp":1786116807159,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M711722"],"award-info":[{"award-number":["2022M711722"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154254","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:01:25Z","timestamp":1783494085000},"page":"154254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Calycosin triggers ferroptosis through modulation of the OTUD6B\/GPX4 axis to suppress triple-negative breast cancer"],"prefix":"10.1016","volume":"830","author":[{"given":"Xue","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0857-5257","authenticated-orcid":false,"given":"Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2654-6709","authenticated-orcid":false,"given":"Erhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154254_bib1","article-title":"Cancer statistics","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.154254_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154254_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s11658-025-00789-5","article-title":"Programmed cell death in triple-negative breast cancer","volume":"30","author":"Liu","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbrc.2026.154254_bib4","article-title":"Subtyping of triple-negative breast cancers: its prognostication and implications in diagnosis of breast origin, ESMO","volume":"9","author":"Hu","year":"2024","journal-title":"Open"},{"key":"10.1016\/j.bbrc.2026.154254_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154254_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154254_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.20892\/j.issn.2095-3941.2025.0655","article-title":"The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer","volume":"23","author":"Chen","year":"2026","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbrc.2026.154254_bib8","doi-asserted-by":"crossref","first-page":"40456","DOI":"10.1021\/acsnano.5c13083","article-title":"Precise ratiometric drug delivery for the treatment of triple-negative breast cancer","volume":"19","author":"Kang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2026.154254_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114389","article-title":"Focused ultrasound-triggered doxorubicin liposomes reshape tumor microenvironment to boost checkpoint depletion in triple-negative breast cancer model","volume":"388","author":"Lee","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2026.154254_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/jamaoncol.2024.3679","article-title":"Heterogeneity of residual disease after neoadjuvant systemic therapy in breast cancer: a review","volume":"10","author":"Tarantino","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbrc.2026.154254_bib11","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.cell.2026.03.024","article-title":"Cell death in cancer","volume":"189","author":"Conrad","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154254_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154254_bib13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","article-title":"Decoding ferroptosis for cancer therapy","volume":"25","author":"Wahida","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154254_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154254_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111869","article-title":"Role of ferroptosis in breast cancer: molecular mechanisms and therapeutic interventions","volume":"134","author":"Wang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.154254_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101349","article-title":"AMPK\u03b12 attenuates doxorubicin induced ferroptosis by promoting NCOA4 degradation in triple negative breast cancer","volume":"85","author":"Liu","year":"2026","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154254_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103775","article-title":"PNKP targeting engages the autophagic machinery through STING and STAT3 to potentiate ferroptosis and chemotherapy in TNBC","volume":"86","author":"Maimon","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrc.2026.154254_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12943-025-02416-5","article-title":"Traditional Chinese medicine in the treatment of breast Cancer","volume":"24","author":"Song","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154254_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jare.2024.09.027","article-title":"Salidroside sensitizes triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy","volume":"74","author":"Huang","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbrc.2026.154254_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2026.158190","article-title":"Momordin Ic targets SREBP1 to disrupt lipid homeostasis and trigger synergistic apoptosis-ferroptosis in triple-negative breast cancer","volume":"155","author":"Cheng","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2026.154254_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/14787210.2021.1863145","article-title":"Calycosin: a review of its pharmacological effects and application prospects","volume":"19","author":"Deng","year":"2020","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.bbrc.2026.154254_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ptr.70172","article-title":"Calycosin targets the CYP1B1-AKT\/SP1-GPX4 axis to modulate ferroptosis in colorectal carcinogenesis","volume":"40","author":"Bie","year":"2026","journal-title":"Phytother Res."},{"key":"10.1016\/j.bbrc.2026.154254_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12032-025-03195-1","article-title":"Pharmacological modulation of Ca2+ signaling by calycosin promotes glioblastoma cell death","volume":"43","author":"Hao","year":"2026","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2026.154254_bib24","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s40001-026-04365-1","article-title":"Targeting ferroptosis in breast cancer: mechanisms, biological functions, and natural product-related therapeutic strategies","volume":"31","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbrc.2026.154254_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101288","article-title":"Drug resistance in breast cancer: mechanisms and strategies for management","volume":"83","author":"Wu","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154254_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","article-title":"Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2026.154254_bib27","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41589-025-01873-9","article-title":"Interfering with GPX4 degradation","volume":"21","author":"Li","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154254_bib28","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.7150\/ijbs.82120","article-title":"Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer","volume":"19","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.154254_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157074","article-title":"Nobiletin promotes ferroptosis in breast cancer through targeting AKR1C1-mediated ubiquitination and degradation of GPX4","volume":"146","author":"Wu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2026.154254_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2025.04.052","article-title":"Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation","volume":"235","author":"Zhang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2026.154254_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2025.12.060","article-title":"Dihydroartemisinin targets GPX4 to induce autophagy-dependent ferroptosis and reduce radioresistance in triple-negative breast cancer","volume":"246","author":"Wu","year":"2026","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2026.154254_bib32","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/acs.accounts.5c00003","article-title":"Strategies for precise modulation of protein degradation","volume":"58","author":"He","year":"2025","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbrc.2026.154254_bib33","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.32604\/or.2025.063644","article-title":"Deubiquitinating enzyme OTUDs: focus on cancers and antiviral response","volume":"33","author":"Chen","year":"2025","journal-title":"Oncol. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:05:47Z","timestamp":1786017947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26010181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S0006291X26010181"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154254","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calycosin triggers ferroptosis through modulation of the OTUD6B\/GPX4 axis to suppress triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154254"}}